"Yourgene Health is an international molecular diagnostics group which develops and commercialises genomic services and technologies. The group works in partnership with global leaders in DNA technology to advance diagnostic science. Yourgene primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and infectious diseases. The Group’s flagship in vitro diagnostic products include non-invasive prenatal tests (NIPT) for Down’s Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests and DPYD genotyping."

During the past decade, Premaitha Health conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Premaitha Health" are "Aneuploidy, NIPT" (1 trials), "Down Syndrome" (1 trials), "Edward's Syndrome" (1 trials) and "Patau Syndrome" (1 trials). Many other conditions were trialed in "Premaitha Health" in a lesser frequency.

Most popular intervention types in "Premaitha Health" are "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood sample" (1 trials). Other intervention names were less common.

The vast majority of trials in "Premaitha Health" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Premaitha Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Premaitha Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Premaitha Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".